Alexion Pharmaceuticals, Inc.
ALXNDelisted Jul 21, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000899866
Alexion Pharmaceuticals, Inc. was delisted on Jul 21, 2021; its insiders filed their last Form 4 on Jul 23, 2021; 711 institutions reported holding it in 13F filings for Q2 2021, worth $39.1B in total; superinvestors Soros Fund Management and Maverick Capital held it.
Superinvestors holding ALXN, Q2 2021
2 superinvestors report holding Alexion Pharmaceuticals, Inc. on Form 13F, worth $94.0M in total. Weight is Alexion Pharmaceuticals, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2021.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 1.7% | 500,001 | $91.9M | New |
| Maverick CapitalLee Ainslie | <0.1% | 11,420 | $2.10M | Reduced−62.3% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ALXN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
2 superinvestors holding at quarter end
- New
- Soros Fund Management
- Reduced
- Maverick Capital (−62.3%)